Sunshine Guojian has 3 listed products and 14 products under development.
The company has a specialized antibody drug development platform and provides technical and intellectual resources to support the “National Engineering Research Center of Antibody Medicine.” The R&D team has more than 200 employees, with more than 45% of researchers having Master’s degree and above. It owns more than 50 patents and has undertaken 18 state-level major projects including “863 Program” and “National Major New Drug Development.”
